Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory Study of TCF-12 in Chronic Kidney Disease
jRCT2080223963Phase 2Terminated
- Sponsor
- Teijin Pharma
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of TCF-12 in chronic kidney disease (CKD) (3 arms), sponsored by Teijin Pharma. Started Jul 2018; status: terminated.
02
Drugs
TCF-12
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on jRCT2080223963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223963.